Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
479 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06103032 | Survival of BCS vs Mx in Asymptomatic Screen-detected NPBC | completed | — | 1,020 | Peking Union Medical College HospitalOTHER | 1 | Oct 26, 2023 | clinicaltrials |
| NCT06090825 | Cross-sectional Survey on Palliative Therapy for Pancreatic Cancer Patient | unknown | — | 450 | Peking Union Medical College HospitalOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT06086327 | Application of 68Ga-Pentixafor PET/CT for Thymoma | unknown | Early Phase 1 | 100 | Peking Union Medical College HospitalOTHER | 1 | Oct 17, 2023 | clinicaltrials |
| NCT06083701 | Phase I/II Study of Linperlisib Plus Chidamide for R/R Peripheral T-cell Lymphoma: a Prospective, Multi-center Study | unknown | Phase 1 / Phase 2 | 32 | Peking Union Medical College HospitalOTHER | 1 | Oct 16, 2023 | clinicaltrials |
| NCT06080620 | The Choice of Treatment Methods and Efficacy of LABC | unknown | N/A | 50 | Peking Union Medical College HospitalOTHER | 1 | Oct 12, 2023 | clinicaltrials |
| NCT05302011 | Neoadjuvant Pembrolizumab Plus Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma | completed | Phase 2 | 28 | Peking Union Medical College HospitalOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT06070740 | First- Line Treatment With Durvalumab Plus XELOX Chemotherapy in Advanced Gastrointestinal Neuroendocrine Carcinoma | recruiting | Phase 2 | 22 | Peking Union Medical College HospitalOTHER | 1 | Oct 6, 2023 | clinicaltrials |
| NCT06062563 | Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid Cancer | unknown | N/A | 10 | Peking Union Medical College HospitalOTHER | 1 | Oct 2, 2023 | clinicaltrials |
| NCT06062927 | Geno-radiomics Based Model for Evaluation of Immunotherapy and Targeted Therapy for Advanced Soft Tissue Sarcoma | recruiting | — | 60 | Peking Union Medical College HospitalOTHER | 1 | Oct 2, 2023 | clinicaltrials |
| NCT06063018 | RC48 Combined With Tislelizumab for Second-line Treatment of HER2 Expression in Recurrent Cervical Cancer | unknown | Phase 2 | 30 | Peking Union Medical College HospitalOTHER | 1 | Oct 2, 2023 | clinicaltrials |
| NCT06041490 | Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation | not yet recruiting | Phase 2 | 88 | Peking Union Medical College HospitalOTHER | 1 | Sep 18, 2023 | clinicaltrials |
| NCT06039891 | Nimotuzumab Plus Tislelizumab for Recurrent and Metastatic Cervical Cancer | not yet recruiting | Phase 2 | 55 | Peking Union Medical College HospitalOTHER | 0 | Sep 15, 2023 | clinicaltrials |
| NCT06037213 | A Real-World Patient-Reported Outcomes Study in Patients With Long-Term Use of Niraparib | unknown | — | 500 | Peking Union Medical College HospitalOTHER | 1 | Sep 14, 2023 | clinicaltrials |
| NCT06037239 | Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study | unknown | Phase 1 / Phase 2 | 53 | Peking Union Medical College HospitalOTHER | 1 | Sep 14, 2023 | clinicaltrials |
| NCT06035016 | Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast Cancer | recruiting | — | 300 | Peking Union Medical College HospitalOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT03334864 | Observational Cohort Study of Advanced Non-small Cell Lung Cancer (CAPTRA-LUNG) | unknown | — | 5,000 | Peking Union Medical College HospitalOTHER | 1 | Sep 11, 2023 | clinicaltrials |
| NCT06030817 | 99mTc-CNDG Injection in the Diagnosis of Malignant Tumors | unknown | N/A | 100 | Peking Union Medical College HospitalOTHER | 1 | Sep 11, 2023 | clinicaltrials |
| NCT05687318 | A Clinical Trial of the Effectiveness and Safety of Software Assisting Diagnose the Intestinal Polyp Digestive Endoscopy by Analysis of Colonoscopy Medical Images From Electronic Digestive Endoscopy Equipment | completed | N/A | 337 | Peking Union Medical College HospitalOTHER | 1 | Sep 6, 2023 | clinicaltrials |
| NCT06015061 | Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL Patients | unknown | — | 20 | Peking Union Medical College HospitalOTHER | 1 | Aug 29, 2023 | clinicaltrials |
| NCT05871762 | Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer(COMREC) | recruiting | — | 3,705 | Peking Union Medical College HospitalOTHER | 1 | Aug 28, 2023 | clinicaltrials |
| NCT05986981 | MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers | unknown | Phase 2 | 20 | Peking Union Medical College HospitalOTHER | 1 | Aug 14, 2023 | clinicaltrials |
| NCT05981066 | A Clinical Study of mRNA Vaccine (ABOR2014/IPM511) in Patients With Advanced Hepatocellular Carcinoma | unknown | N/A | 48 | Peking Union Medical College HospitalOTHER | 1 | Aug 8, 2023 | clinicaltrials |
| NCT05978349 | PTC Drug Sensitivity Detection to Guide Postoperative Adjuvant of Colorectal Cancer | unknown | N/A | 150 | Peking Union Medical College HospitalOTHER | 1 | Aug 7, 2023 | clinicaltrials |
| NCT05932082 | The Impact of Myomectomy on IVF Outcomes | unknown | N/A | 792 | Peking Union Medical College HospitalOTHER | 0 | Aug 4, 2023 | clinicaltrials |
| NCT05911789 | Online Adaptive Radiation Therapy for Rectal Cancer | unknown | Phase 1 / Phase 2 | 15 | Peking Union Medical College HospitalOTHER | 0 | Aug 1, 2023 | clinicaltrials |
| NCT05879471 | 68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma | unknown | Phase 2 | 39 | Peking Union Medical College HospitalOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT05955092 | Exploring the Application of 3D Bioprinting for Personalized Treatment in Pancreatic Ductal Adenocarcinoma | unknown | — | 30 | Peking Union Medical College HospitalOTHER | 1 | Jul 21, 2023 | clinicaltrials |
| NCT05950490 | Construction of Diagnosis and Treatment System for Primary Vitreoretinal Lymphoma | unknown | — | 100 | Peking Union Medical College HospitalOTHER | 1 | Jul 18, 2023 | clinicaltrials |
| NCT05879497 | 68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion | unknown | Phase 2 | 40 | Peking Union Medical College HospitalOTHER | 1 | Jul 13, 2023 | clinicaltrials |
| NCT05879510 | 68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses | unknown | Phase 2 | 63 | Peking Union Medical College HospitalOTHER | 1 | Jul 13, 2023 | clinicaltrials |
| NCT05937919 | 68Ga-PMD22 PET/CT Examination Targeting CLDN18.2 | unknown | Early Phase 1 | 10 | Peking Union Medical College HospitalOTHER | 1 | Jul 10, 2023 | clinicaltrials |
| NCT04445532 | Hepatobiliary Tumors Tissue Samples Acquisition | unknown | — | 450 | Peking Union Medical College HospitalOTHER | 1 | Jul 7, 2023 | clinicaltrials |
| NCT05690906 | Evaluate the Effect of ReSpace™ Hydrogel on Reducing Rectal Radiation Dose in Radiotherapy for Cervical Cancer | unknown | Phase 2 | 100 | Peking Union Medical College HospitalOTHER | 1 | Jul 6, 2023 | clinicaltrials |
| NCT05932121 | Cross-sectional Case and Control Study on Quality of Life, Appearance and Functions in PTC Via Different Surgical Approach | unknown | — | 300 | Peking Union Medical College HospitalOTHER | 1 | Jul 6, 2023 | clinicaltrials |
| NCT05931055 | The Effectiveness of Liquid Biopsy in Differential Diagnosis and Early Screening of Epithelial Ovarian Cancer | not yet recruiting | — | 1,000 | Peking Union Medical College HospitalOTHER | 0 | Jul 5, 2023 | clinicaltrials |
| NCT04803851 | Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 29 | Peking Union Medical College HospitalOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05902377 | 68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma | unknown | Phase 2 | 46 | Peking Union Medical College HospitalOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT05902390 | The Long-term Benefit of Hydrogel Spacer in Reducing Rectal Radiation Dose in Cervical Cancer Radiation Therapy. | unknown | N/A | 106 | Peking Union Medical College HospitalOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT05891028 | 64Cu/68Ga Labelled EB-ss-CPT PET/CT Scan in Colorectal Cancer | unknown | Early Phase 1 | 10 | Peking Union Medical College HospitalOTHER | 1 | Jun 8, 2023 | clinicaltrials |
| NCT05885399 | The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment | unknown | Phase 2 | 5 | Peking Union Medical College HospitalOTHER | 1 | Jun 2, 2023 | clinicaltrials |
| NCT05885386 | A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL | unknown | Phase 2 | 20 | Peking Union Medical College HospitalOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT05883085 | A Study on the Safety and Effectiveness of Anlotinib for Neoadjuvant Treatment of PPGL | unknown | Phase 2 | 10 | Peking Union Medical College HospitalOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05875753 | 68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer | unknown | Early Phase 1 | 50 | Peking Union Medical College HospitalOTHER | 1 | May 25, 2023 | clinicaltrials |
| NCT05171517 | Study on Microflora Characteristics of Pancreatic Solid Lesions Via Endoscopic Ultrasound-guided Fine Needle Aspiration/Biopsy | completed | — | 200 | Peking Union Medical College HospitalOTHER | 1 | May 23, 2023 | clinicaltrials |
| NCT05858177 | The Efficacy and Safety of Temozolomide in Patients With MPPGL(MPPGL) | completed | Phase 2 | 62 | Peking Union Medical College HospitalOTHER | 1 | May 15, 2023 | clinicaltrials |
| NCT05853549 | Clinical Implementation of Surface-guided Radiation Therapy in Vulvar Cancer | completed | N/A | 10 | Peking Union Medical College HospitalOTHER | 1 | May 10, 2023 | clinicaltrials |
| NCT05842746 | Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma | not yet recruiting | Phase 2 | 74 | Peking Union Medical College HospitalOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT05841992 | Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients | unknown | Phase 2 / Phase 3 | 100 | Peking Union Medical College HospitalOTHER | 1 | May 3, 2023 | clinicaltrials |
| NCT05822453 | Gemcitabine Plus S1 and Tislelizumab in the First Line Therapy of Advanced Biliary Tract Carcinoma | unknown | Phase 2 | 20 | Peking Union Medical College HospitalOTHER | 1 | Apr 20, 2023 | clinicaltrials |
| NCT03048877 | Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer | unknown | Phase 3 | 118 | Peking Union Medical College HospitalOTHER | 1 | Apr 12, 2023 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials